Your browser doesn't support javascript.
loading
Dynamic predictive probabilities to monitor rapid cystic fibrosis disease progression.
Szczesniak, Rhonda D; Su, Weiji; Brokamp, Cole; Keogh, Ruth H; Pestian, John P; Seid, Michael; Diggle, Peter J; Clancy, John P.
Afiliación
  • Szczesniak RD; Division of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
  • Su W; Department of Mathematical Sciences, University of Cincinnati, Cincinnati, Ohio.
  • Brokamp C; Division of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
  • Keogh RH; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
  • Pestian JP; Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, and Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
  • Seid M; James M. Anderson Center for Health Systems Excellence and Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
  • Diggle PJ; CHICAS, Lancaster Medical School Lancaster University Lancaster, UK and Health Data Research UK, London, UK.
  • Clancy JP; Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
Stat Med ; 39(6): 740-756, 2020 03 15.
Article en En | MEDLINE | ID: mdl-31816119
ABSTRACT
Cystic fibrosis (CF) is a progressive, genetic disease characterized by frequent, prolonged drops in lung function. Accurately predicting rapid underlying lung-function decline is essential for clinical decision support and timely intervention. Determining whether an individual is experiencing a period of rapid decline is complicated due to its heterogeneous timing and extent, and error component of the measured lung function. We construct individualized predictive probabilities for "nowcasting" rapid decline. We assume each patient's true longitudinal lung function, S(t), follows a nonlinear, nonstationary stochastic process, and accommodate between-patient heterogeneity through random effects. Corresponding lung-function decline at time t is defined as the rate of change, S'(t). We predict S'(t) conditional on observed covariate and measurement history by modeling a measured lung function as a noisy version of S(t). The method is applied to data on 30 879 US CF Registry patients. Results are contrasted with a currently employed decision rule using single-center data on 212 individuals. Rapid decline is identified earlier using predictive probabilities than the center's currently employed decision rule (mean difference 0.65 years; 95% confidence interval (CI) 0.41, 0.89). We constructed a bootstrapping algorithm to obtain CIs for predictive probabilities. We illustrate real-time implementation with R Shiny. Predictive accuracy is investigated using empirical simulations, which suggest this approach more accurately detects peak decline, compared with a uniform threshold of rapid decline. Median area under the ROC curve estimates (Q1-Q3) were 0.817 (0.814-0.822) and 0.745 (0.741-0.747), respectively, implying reasonable accuracy for both. This article demonstrates how individualized rate of change estimates can be coupled with probabilistic predictive inference and implementation for a useful medical-monitoring approach.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrosis Quística Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Stat Med Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrosis Quística Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Stat Med Año: 2020 Tipo del documento: Article